Chemotherapeutic agent - Hutchinson encyclopedia article about Chemotherapeutic agent Printer Friendly
Dictionary, Encyclopedia and Thesaurus - The Free Dictionary
1,515,229,616 visitors served.
forum mailing list For webmasters
?
New: Language forums
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

agent
(redirected from Chemotherapeutic agent)

    Also found in: Dictionary/thesaurus, Medical, Legal, Financial, Encyclopedia, Wikipedia 0.17 sec.

agent

Software that mimics intelligence by automating tasks according to user-defined rules. Agents might select news stories of interest to users based on information users have already supplied, arrange scheduling with other agents, and filter out unwanted junk e-mail.

agent

In business, party with authority to act on behalf of another in dealings with third parties. The party the agent acts on behalf of is called the principal. With regard to legal obligations, the principal is bound by the actions of the agent provided the agent is acting within its authority. Typical examples of the agent–principal relationship include lawyers granted the power of attorney, and estate agents.



How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content.
?Page tools
Printer friendly
Cite / link
 Email
Feedback
?Sign in SSL protected
Email:
Password:
Register

? Mentioned in ? References in periodicals archive
 
As reported in this month's issue, a research group exposed cultures of immature neurons known as granule cells and the more developed and more abundant astrocytes to sublethal doses of two well-characterized alkylating genotoxicants: methylazoxymethanol (MAM), a highly toxic compound synthesized from the poison found in plants called cycads, and nitrogen mustard (HN2), a chemotherapeutic agent.
New neurons at risk: genotoxicants and brain development by Hood, Ernie / Environmental Health Perspectives
Revimmune is based on pulsed, ultra-high dosing of a well-known chemotherapeutic agent under a risk management program.
Company Profile for Accentia Biopharmaceuticals, Inc by Business Wire
The Phase II clinical trial, which is ongoing at the National Cancer Institute (NCI), is testing use of the Delcath System for the organ-specific delivery of the chemotherapeutic agent, melphalan, in patients with specific tumors in the liver, including primary liver cancer, metastatic neuroendocrine tumors and adenocarcinomas in the liver.
Delcath Expands Phase II Multi-Histology Clinical Trial by Business Wire
More results
 
Hutchinson browser? ? Full browser
 
 
Hutchinson Encyclopedia
?

Disclaimer | Privacy policy | Feedback | Copyright © 2009 Farlex, Inc.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. Terms of Use.